|
Generic Name : Teniposide
Pronunciation : ten-i-POE-side
Therapeutic Classification : Chemotherapy
Trade Name(s):
International- Vumon. This medication is an antineoplastic agent, prescribed for leukemia in combination with other medications. When it is not to be taken (Contraindications):
When it is to be taken : IV- The recommended dose is Teniposide 165 mg/m2 and cytarabine 300 mg/m 2 twice weekly for 8 to 9 doses. How it should be taken : It comes as a solution for injection, to be administered by a healthcare provider into the vein. Special Instruction : * It may cause drowsiness, dizziness, or blurred vision, do not drive a car or operate machinery while taking this medication. * Do not receive any vaccination while taking this medication. * Monitor complete blood count, kidney and liver functions regularly. * It may reduce the platelet counts in blood, avoid unusual bruising or bleeding. * It may reduce the number of white blood cells and lead to infections. * Caution should be exercised in patients with history of Down syndrome, alcoholism, elderly patients, during pregnancy and breastfeeding. * It may result in hair loss. Side Effects : Heart - Low blood pressure. Skin - Hair loss and rash. Gastrointestinal - Painful ulceration, diarrhea and nausea/vomiting. Blood - Anemia, decrease in white blood cells and platelets, and bleeding. Hypersensitivity - Hypersensitivity reactions such as asthma, chills, difficulty in breathing, fever, flushing, high blood pressure and fast heart rate. Miscellaneous - Infection and fever. * It should not be used in infants and newborns. Storage Conditions : Store the unopened ampules under refrigeration (2°-8°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||


